Dr. Ryosuke Takahashi, the Brain/MINDS 2.0 Program Supervisor, shares with Dr. Judy Illes, the IBI Chair, that a project led by the University of Tokyo has been recently selected, under the Brain/MINDS 2.0 initiative, to provide neuroethical consultation for other neuroscience projects, and to conduct neuroethics research. On that note, Dr. Takahashi probes into the ethical implications of diagnosing Alzheimer’s, Parkinson’s and other neurodegenerative diseases.

IBI Chair, Dr. Judy Illes, recently hosted a conversation with Drs. Ryosuke Takahashi, Makoto Sugawa, Tetsushi Kagawa and Ms. Yumiko Miyashita, to discuss the relationship between the Brain/MINDS 2.0 research program in Japan and the IBI in advancing the goals of global neuroscience.

The Hastings Center recently announced the election of its 2024 Fellows, including Neuroethics Canada’s Dr. Judy Illes. Hastings Center Fellows are a group of more than 200 individuals of outstanding accomplishment whose work has informed scholarship and public understanding of complex ethical issues in health, health care, science, and technology.

Launched in 2013, the BRAIN Initiative (BRAIN) in the United States aimed to unlock the mysteries of the brain and develop new treatments for neurological and neuropsychiatric disorders. The success of this program is evidenced by the accelerated discoveries and development of interventions that are happening in real time. However, a recent 40% cut in funding for BRAIN threatens this once-in-a-generation opportunity to solve fundamental mysteries of the brain and achieve treatment breakthroughs that we once thought impossible.

IBI Chair, Dr. Judy Illes, recently hosted a conversation with Dr. Yves De Koninck, to discuss the relationship between the Canadian Brain Research Strategy (CBRS) and the International Brain Initiative (IBI) in advancing global neuroscience collaboration.